Associations between sensory processing and electrophysiological and neurochemical measures in children with ASD: an EEG-MRS study.
Alpha power
Autism spectrum disorder
EEG
GABA
Glutamate
MRS
Sensory processing
Journal
Journal of neurodevelopmental disorders
ISSN: 1866-1955
Titre abrégé: J Neurodev Disord
Pays: England
ID NLM: 101483832
Informations de publication
Date de publication:
06 01 2021
06 01 2021
Historique:
received:
20
09
2020
accepted:
14
12
2020
entrez:
7
1
2021
pubmed:
8
1
2021
medline:
27
8
2021
Statut:
epublish
Résumé
Autism spectrum disorder (ASD) is associated with hyper- and/or hypo-sensitivity to sensory input. Spontaneous alpha power, which plays an important role in shaping responsivity to sensory information, is reduced across the lifespan in individuals with ASD. Furthermore, an excitatory/inhibitory imbalance has also been linked to sensory dysfunction in ASD and has been hypothesized to underlie atypical patterns of spontaneous brain activity. The present study examined whether resting-state alpha power differed in children with ASD as compared to TD children, and investigated the relationships between alpha levels, concentrations of excitatory and inhibitory neurotransmitters, and atypical sensory processing in ASD. Participants included thirty-one children and adolescents with ASD and thirty-one age- and IQ-matched typically developing (TD) participants. Resting-state electroencephalography (EEG) was used to obtain measures of alpha power. A subset of participants (ASD = 16; TD = 16) also completed a magnetic resonance spectroscopy (MRS) protocol in order to measure concentrations of excitatory (glutamate + glutamine; Glx) and inhibitory (GABA) neurotransmitters. Children with ASD evidenced significantly decreased resting alpha power compared to their TD peers. MRS estimates of GABA and Glx did not differ between groups with the exception of Glx in the temporal-parietal junction. Inter-individual differences in alpha power within the ASD group were not associated with region-specific concentrations of GABA or Glx, nor were they associated with sensory processing differences. However, atypically decreased Glx was associated with increased sensory impairment in children with ASD. Although we replicated prior reports of decreased alpha power in ASD, atypically reduced alpha was not related to neurochemical differences or sensory symptoms in ASD. Instead, reduced Glx in the temporal-parietal cortex was associated with greater hyper-sensitivity in ASD. Together, these findings may provide insight into the neural underpinnings of sensory processing differences present in ASD.
Sections du résumé
BACKGROUND
Autism spectrum disorder (ASD) is associated with hyper- and/or hypo-sensitivity to sensory input. Spontaneous alpha power, which plays an important role in shaping responsivity to sensory information, is reduced across the lifespan in individuals with ASD. Furthermore, an excitatory/inhibitory imbalance has also been linked to sensory dysfunction in ASD and has been hypothesized to underlie atypical patterns of spontaneous brain activity. The present study examined whether resting-state alpha power differed in children with ASD as compared to TD children, and investigated the relationships between alpha levels, concentrations of excitatory and inhibitory neurotransmitters, and atypical sensory processing in ASD.
METHODS
Participants included thirty-one children and adolescents with ASD and thirty-one age- and IQ-matched typically developing (TD) participants. Resting-state electroencephalography (EEG) was used to obtain measures of alpha power. A subset of participants (ASD = 16; TD = 16) also completed a magnetic resonance spectroscopy (MRS) protocol in order to measure concentrations of excitatory (glutamate + glutamine; Glx) and inhibitory (GABA) neurotransmitters.
RESULTS
Children with ASD evidenced significantly decreased resting alpha power compared to their TD peers. MRS estimates of GABA and Glx did not differ between groups with the exception of Glx in the temporal-parietal junction. Inter-individual differences in alpha power within the ASD group were not associated with region-specific concentrations of GABA or Glx, nor were they associated with sensory processing differences. However, atypically decreased Glx was associated with increased sensory impairment in children with ASD.
CONCLUSIONS
Although we replicated prior reports of decreased alpha power in ASD, atypically reduced alpha was not related to neurochemical differences or sensory symptoms in ASD. Instead, reduced Glx in the temporal-parietal cortex was associated with greater hyper-sensitivity in ASD. Together, these findings may provide insight into the neural underpinnings of sensory processing differences present in ASD.
Identifiants
pubmed: 33407072
doi: 10.1186/s11689-020-09351-0
pii: 10.1186/s11689-020-09351-0
pmc: PMC7788714
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
5Subventions
Organisme : NIMH NIH HHS
ID : R21 MH114095
Pays : United States
Organisme : NIH HHS
ID : S10 OD012336
Pays : United States
Organisme : NIMH NIH HHS
ID : T32 MH073124
Pays : United States
Organisme : ODCDC CDC HHS
ID : S10 OD012336
Pays : United States
Références
Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):11053-8
pubmed: 12958209
Autism Res. 2019 Apr;12(4):562-575
pubmed: 30632707
J Autism Dev Disord. 2015 Jan;45(1):230-44
pubmed: 25245785
Front Hum Neurosci. 2014 May 14;8:302
pubmed: 24860482
Magn Reson Med. 1993 Dec;30(6):672-9
pubmed: 8139448
J Autism Dev Disord. 2017 Sep;47(9):2710-2722
pubmed: 28597185
Nat Rev Neurosci. 2011 Aug 10;12(9):509-23
pubmed: 21829219
Front Neurosci. 2020 May 19;14:482
pubmed: 32508576
JAMA Psychiatry. 2015 Aug;72(8):767-77
pubmed: 26061743
Nat Neurosci. 2000 Mar;3(3):277-83
pubmed: 10700261
Learn Mem. 1997 May-Jun;4(1):1-35
pubmed: 10456051
Neurosci Biobehav Rev. 2018 Apr;87:106-117
pubmed: 29408312
J Neurosci. 2009 Mar 4;29(9):2725-32
pubmed: 19261866
J Child Psychol Psychiatry. 2019 Mar;60(3):314-324
pubmed: 30350375
Neuroimage. 2004 Jun;22(2):637-44
pubmed: 15193592
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15220-5
pubmed: 25288765
J Child Psychol Psychiatry. 2005 Feb;46(2):211-22
pubmed: 15679529
J Autism Dev Disord. 2018 Jan;48(1):110-122
pubmed: 28900800
Trends Cogn Sci. 2012 Dec;16(12):606-17
pubmed: 23141428
Psychiatry Res. 2008 Jul 15;163(2):97-105
pubmed: 18508243
J Child Psychol Psychiatry. 2006 Jun;47(6):591-601
pubmed: 16712636
Brain Connect. 2020 Feb;10(1):18-28
pubmed: 31884804
J Autism Dev Disord. 2012 Sep;42(9):1884-94
pubmed: 22207057
J Neurodev Disord. 2013 Sep 16;5(1):24
pubmed: 24040879
Autism Res. 2017 Apr;10(4):608-619
pubmed: 27611990
Front Psychol. 2011 May 19;2:99
pubmed: 21779257
Cortex. 2019 Sep;118:38-50
pubmed: 30808550
PLoS One. 2012;7(6):e39127
pubmed: 22745707
Transl Psychiatry. 2014 Feb 18;4:e364
pubmed: 24548879
Psychophysiology. 2018 Jul;55(7):e13064
pubmed: 29357113
J Autism Dev Disord. 2001 Apr;31(2):247-8
pubmed: 11450824
Clin Neurophysiol. 2004 May;115(5):1145-60
pubmed: 15066540
J Neurosci Methods. 2015 Jul 30;250:47-63
pubmed: 25791012
Philos Trans R Soc Lond B Biol Sci. 2005 Apr 29;360(1456):815-36
pubmed: 15937014
Front Hum Neurosci. 2010 Nov 04;4:186
pubmed: 21119777
J Cogn Neurosci. 2014 Oct;26(10):2400-15
pubmed: 24702458
Front Hum Neurosci. 2017 Sep 06;11:446
pubmed: 28932189
Dev Cogn Neurosci. 2018 Jan;29:41-53
pubmed: 28889988
Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Aug;3(8):667-674
pubmed: 29628433
Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Jan;2(1):76-84
pubmed: 28584881
Brain Res. 2011 Mar 22;1380:198-205
pubmed: 21185269
Psychophysiology. 2015 Sep;52(9):1131-9
pubmed: 25917405
Int J Psychophysiol. 2016 May;103:12-21
pubmed: 25659527
Clin Neurophysiol. 2012 Sep;123(9):1798-809
pubmed: 22405935
J Autism Dev Disord. 2015 Mar;45(3):795-804
pubmed: 25231288
J Abnorm Child Psychol. 1995 Oct;23(5):569-83
pubmed: 8568080
Comput Intell Neurosci. 2011;2011:130714
pubmed: 21687590
MMWR Surveill Summ. 2020 Mar 27;69(4):1-12
pubmed: 32214087
Magn Reson Med. 2007 Oct;58(4):813-8
pubmed: 17899586
Neuron. 2009 Sep 10;63(5):683-96
pubmed: 19755110
Biol Psychiatry. 2007 Feb 15;61(4):465-73
pubmed: 17276747
J Cogn Neurosci. 2010 Feb;22(2):307-22
pubmed: 19400673
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:236-244
pubmed: 30248378
Front Psychol. 2011 Jul 05;2:154
pubmed: 21779269
Biol Psychiatry. 2007 Aug 1;62(3):270-3
pubmed: 17336944
Magn Reson Med. 2012 Oct;68(4):1018-25
pubmed: 22213204
Sci Rep. 2020 Sep 14;10(1):15059
pubmed: 32929186
Nat Commun. 2020 May 29;11(1):2675
pubmed: 32472088
Psychol Rev. 2014 Oct;121(4):649-75
pubmed: 25347312
Dev Psychopathol. 2013 May;25(2):307-20
pubmed: 23627946
Transl Psychiatry. 2018 May 25;8(1):106
pubmed: 29802263
Mol Psychiatry. 2020 May 6;:
pubmed: 32376999
Autism Res. 2020 Apr;13(4):550-562
pubmed: 31909886
Prog Neurobiol. 2015 Nov;134:140-60
pubmed: 26455789
J Magn Reson Imaging. 2015 Nov;42(5):1431-40
pubmed: 26172043
Neuroimage. 2007 Oct 1;37(4):1465-73
pubmed: 17706433
J Neurophysiol. 2002 Jan;87(1):615-20
pubmed: 11784775
Neurosci Biobehav Rev. 2016 Sep;68:848-861
pubmed: 27451342
Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Sep;2(6):528-536
pubmed: 29170759
J Neurodev Disord. 2017 Sep 13;9(1):34
pubmed: 28903722
Mol Psychiatry. 2014 Dec;19(12):1314-25
pubmed: 25048006
Mov Disord. 2013 Feb;28(2):201-9
pubmed: 23239076
Brain Cogn. 2014 Apr;86:55-63
pubmed: 24565813
J Neurosci. 2010 Jul 28;30(30):10243-50
pubmed: 20668207
Res Autism Spectr Disord. 2019 Jan;57:132-144
pubmed: 31223334
Nat Neurosci. 2010 Jul;13(7):825-7
pubmed: 20512136
Clin Neurophysiol. 2008 May;119(5):1002-9
pubmed: 18331812
Genes Brain Behav. 2003 Oct;2(5):255-67
pubmed: 14606691